Clicky

Broncus Holding Corp(2216)

Description: Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally. The company provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus, a system that provides real-time navigation within the airways for lung biopsy and other procedures; and LungPro, a virtual bronchoscopic navigation product that provides three-dimensional real-time guided transbronchial needle aspiration and proprietary parenchymal navigation. It also offers treatment products comprising InterVapor, a targeted bronchoscopic thermal vapor ablation to ablate the diseased hyper-inflated lung segments; RF Generator + RF Ablation Catheter, a radiofrequency ablation system used in conjunction with a disposable lung radiofrequency ablation catheter, as well as radiofrequency ablation system that targets lung cancer; and H-Marker, a pulmonary surgical marker. In addition, the company provides treatment products, such as BioStarNeedle, a single use ultrasound-guided aspiration needle for retrieval of tissue samples; FleXNeedle, a multipurpose biopsy needle; Archimedes Sheath, a sterile single-use flexible tube that provides a working channel during a bronchoscopic procedure; Archimedes Dilation Balloon, a sterile single-use flexible tube with a balloon at or near the distal tip that is inserted through the bronchoscope or sheath and used to dilate the target lung tissue of the bronchial tree; and Steerable Sheath, a steerable sheath adjustment handle and a working channel. Broncus Holding Corporation was incorporated in 2012 and is headquartered in Hangzhou, China.


Keywords: Medicine Clinical Medicine Ultrasound Catheter Lung Cancer Interventional Radiology Endoscopy Treatment Products Biopsy Navigation Products Surgical Oncology Radiofrequency Ablation Bronchoscopy

Home Page: www.broncus.com

Room 801, Building 8
Hangzhou,
China
Phone:


Officers

Name Title
Mr. Guowei Zhan CEO, GM & Exec. Director
Mr. Hong Xu CTO & Exec. Director
Mr. Todd A. Cornell Pres of Broncus Medical & Uptake Medical
Thomas M. Keast VP, Operation Director & Scientist in resident
Feng Yao Sr. Accountant
Ms. Elaine Lu Director of Fin. & Admin.
Ms. Yin Kwan Ho Company Sec.

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.6656
Price-to-Sales TTM: 107.3777
IPO Date:
Fiscal Year End: December
Full Time Employees: 320
Back to stocks